Cargando…
Biomarker-driven management strategies for peripheral T cell lymphoma
Peripheral T cell lymphomas are heterogeneous diseases which remain treatment challenges. Recent advances in molecular and genomic profiling have provided unprecedented insight into disease pathogenesis driven by distinct cells of origins and molecular pathways. The discovery and clinical applicatio...
Autores principales: | Mulvey, Erin, Ruan, Jia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245625/ https://www.ncbi.nlm.nih.gov/pubmed/32448357 http://dx.doi.org/10.1186/s13045-020-00889-z |
Ejemplares similares
-
Peripheral T-Cell Lymphoma: Review and Updates of Current Management Strategies
por: Tang, Tiffany, et al.
Publicado: (2010) -
Toward a Biology-Driven Treatment Strategy for Peripheral T-cell Lymphoma
por: Hildyard, CAT, et al.
Publicado: (2017) -
An update on the management of peripheral T-cell lymphoma and emerging treatment options
por: Phillips, Adrienne A, et al.
Publicado: (2011) -
Recent Advances in the Management of Relapsed and Refractory Peripheral T-Cell Lymphomas
por: Braunstein, Zachary, et al.
Publicado: (2022) -
Critical appraisal of pralatrexate in the management of difficult-to-treat peripheral T cell lymphoma
por: Casanova, M, et al.
Publicado: (2011)